Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Etienne Brain

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Nature Medicine|March 6, 2023
Evolution of synchronous female bilateral breast cancers and response to treatmentAnne-Sophie Hamy, Judith Abécassis, Keltouma Driouch, et al.
Bulletin Du Cancer|July 31, 2016
[Breast cancer screening: On our way to the future]Suzette Delaloge, Thomas Bachelot, François-Clément Bidard, et al.
Bulletin Du Cancer|December 29, 2016
[Erratum to: "Breast cancer screening: On our way to the future" [Bull. Cancer 103 (2016) 753-763]]Suzette Delaloge, Thomas Bachelot, François-Clément Bidard, et al.
The Lancet. Oncology|March 15, 2021
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by ageMartine Piccart, Laura J van 't Veer, Coralie Poncet, et al.
The New England Journal of Medicine|August 25, 2016
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast CancerFatima Cardoso, Laura J van't Veer, Jan Bogaerts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2020
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i>-Mutant Metastatic Non-Small Cell Lung CancerSandra Ortiz-Cuaran, Laura Mezquita, Aurélie Swalduz, et al.
Breast (Edinburgh, Scotland)|February 13, 2025
An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42Vesna Bjelic-Radisic, Fatima Cardoso, Joachim Weis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2024
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g<i>BRCA1/2</i> Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast CancerPatricia A Ganz, Hanna Bandos, Tanja Španić, et al.
JAMA Oncology|December 18, 2025
Enhancing Clinical Cancer Research Through Sharing of Data and BiospecimensHans Wildiers, Virginie Adam, Seamus O'Reilly, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Nature Medicine|March 6, 2023
Evolution of synchronous female bilateral breast cancers and response to treatmentAnne-Sophie Hamy, Judith Abécassis, Keltouma Driouch, et al.
Bulletin Du Cancer|July 31, 2016
[Breast cancer screening: On our way to the future]Suzette Delaloge, Thomas Bachelot, François-Clément Bidard, et al.
Bulletin Du Cancer|December 29, 2016
[Erratum to: "Breast cancer screening: On our way to the future" [Bull. Cancer 103 (2016) 753-763]]Suzette Delaloge, Thomas Bachelot, François-Clément Bidard, et al.
The Lancet. Oncology|March 15, 2021
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by ageMartine Piccart, Laura J van 't Veer, Coralie Poncet, et al.
The New England Journal of Medicine|August 25, 2016
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast CancerFatima Cardoso, Laura J van't Veer, Jan Bogaerts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2020
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i>-Mutant Metastatic Non-Small Cell Lung CancerSandra Ortiz-Cuaran, Laura Mezquita, Aurélie Swalduz, et al.
Breast (Edinburgh, Scotland)|February 13, 2025
An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42Vesna Bjelic-Radisic, Fatima Cardoso, Joachim Weis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2024
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g<i>BRCA1/2</i> Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast CancerPatricia A Ganz, Hanna Bandos, Tanja Španić, et al.
JAMA Oncology|December 18, 2025
Enhancing Clinical Cancer Research Through Sharing of Data and BiospecimensHans Wildiers, Virginie Adam, Seamus O'Reilly, et al.
Pageof 14